C Xiang, H Li, W Tang - Pharmacological Research, 2023 - Elsevier
Abstract Colony-stimulating factor-1 receptor (CSF-1R), also known as FMS kinase, is a type I single transmembrane protein mainly expressed in myeloid cells, such as monocytes …
YA Makarova, VA Ryabkova, VV Salukhov, BV Sagun… - Diagnostics, 2023 - mdpi.com
The article describes how atherosclerosis and coronavirus disease 19 (COVID-19) may affect each other. The features of this comorbid pathogenesis at various levels (vascular …
J Xu, X Han, N Xia, Q Zhao… - Experimental and …, 2023 - spandidos-publications.com
IL‑37 is a newly discovered inflammatory factor. However, the protective effect and underlying mechanisms of IL‑37 on atherosclerosis remain unclear. In the present study, IL …
M Gu, Y Jin, X Gao, W Xia, T Xu, S Pan - Frontiers in Immunology, 2023 - frontiersin.org
Interleukin-37 (IL-37) is a newly discovered member of IL-1 family. The cytokine was proved to have extensive protective effects in infectious diseases, allergic diseases, metabolic …
R Saigusa, J Vallejo, R Gulati, SSA Suthahar… - International journal of …, 2022 - mdpi.com
Despite the decades-old knowledge that males and people with diabetes mellitus (DM) are at increased risk for coronary artery disease (CAD), the reasons for this association are only …
M Tomasi, A Cherubini, S Pelusi, S Margarita… - International Journal of …, 2023 - mdpi.com
Fatty liver disease is most frequently related to metabolic dysfunction (MAFLD) and associated comorbidities, heightening the risk of cardiovascular disease, and is associated …
The COVID-19 pandemic involved millions of people and diabetes was identified as an associated comorbidity. Initiation of systemic corticosteroids in patients suffering from severe …
B Zamani, M Najafizadeh… - International …, 2022 - journals.sagepub.com
Objective Immune changes play fundamental roles in the pathogenesis and severity of coronavirus disease 2019 (COVID-19). Previous studies have revealed alterations in …
J Shang, Y Xu, S Pu, X Sun, X Gao - Cytokine, 2023 - Elsevier
In recent years, IL-34 has been widely discussed as a novel cytokine. IL-34 is a pro- inflammatory cytokine binding four distinct receptors, namely CSF-1R, syndecan-1, PTP-ζ …